Comparison of change in left and right heart structures before and after Super Glenn based on cardiac magnetic resonance imaging
MRI data . | ||||
---|---|---|---|---|
Variable . | N . | Pre-Super Glenn median (IQR) . | Post-Super Glenn median (IQR) . | P-value . |
i LV EDV (ml/m2) | 27 | 30.00 (23.88–36.53) | 51.96 (41.13–64.73) | <0.001 |
i LV ESV (ml/m2) | 27 | 11.94 (8.17–16.01) | 20.81 (15.29–28.22) | <0.001 |
i LV SV (ml/m2) | 27 | 16.91 (13.52–20.51) | 27.58 (24.66–37.19) | <0.001 |
LV EF (%) | 27 | 57.90 (54.20–64.00) | 60.90 (53.60–62.65) | 0.40 |
i LV mass (g/m2) | 25 | 24.38 (19.43–34.73) | 35.28 (27.97–42.46) | <0.001 |
LV mass/volume ratio | 24 | 0.85 (0.69–1.16) | 0.70 (0.58–0.76) | <0.001 |
i RV EDV (ml/m2) | 27 | 106.67 (82.70–119.83) | 86.96 (76.30–121.75) | 0.74 |
i RV ESV (ml/m2) | 27 | 43.75 (32.43–54.89) | 46.18 (39.08–68.14) | 0.12 |
i RV SV (ml/m2) | 27 | 55.00 (43.03–65.99) | 42.04 (37.60–51.99) | 0.068 |
RV EF (%) | 27 | 50.70 (48.95–58.95) | 48.90 (44.75–52.40) | <0.001 |
i RV mass (g/m2) | 25 | 38.80 (29.52–41.89) | 32.03 (26.61–45.76) | 0.41 |
RV mass/volume ratio | 25 | 0.36 (0.31–0.38) | 0.35 (0.27–0.42) | 0.90 |
Mitral:tricuspid inflow ratio | 14 | 0.33 (0.26–0.41) | 0.82 (0.63–1.27) | 0.002 |
LVEDV:RVEDV ratio | 27 | 0.30 (0.25–0.40) | 0.57 (0.36–0.71) | <0.001 |
MRI data . | ||||
---|---|---|---|---|
Variable . | N . | Pre-Super Glenn median (IQR) . | Post-Super Glenn median (IQR) . | P-value . |
i LV EDV (ml/m2) | 27 | 30.00 (23.88–36.53) | 51.96 (41.13–64.73) | <0.001 |
i LV ESV (ml/m2) | 27 | 11.94 (8.17–16.01) | 20.81 (15.29–28.22) | <0.001 |
i LV SV (ml/m2) | 27 | 16.91 (13.52–20.51) | 27.58 (24.66–37.19) | <0.001 |
LV EF (%) | 27 | 57.90 (54.20–64.00) | 60.90 (53.60–62.65) | 0.40 |
i LV mass (g/m2) | 25 | 24.38 (19.43–34.73) | 35.28 (27.97–42.46) | <0.001 |
LV mass/volume ratio | 24 | 0.85 (0.69–1.16) | 0.70 (0.58–0.76) | <0.001 |
i RV EDV (ml/m2) | 27 | 106.67 (82.70–119.83) | 86.96 (76.30–121.75) | 0.74 |
i RV ESV (ml/m2) | 27 | 43.75 (32.43–54.89) | 46.18 (39.08–68.14) | 0.12 |
i RV SV (ml/m2) | 27 | 55.00 (43.03–65.99) | 42.04 (37.60–51.99) | 0.068 |
RV EF (%) | 27 | 50.70 (48.95–58.95) | 48.90 (44.75–52.40) | <0.001 |
i RV mass (g/m2) | 25 | 38.80 (29.52–41.89) | 32.03 (26.61–45.76) | 0.41 |
RV mass/volume ratio | 25 | 0.36 (0.31–0.38) | 0.35 (0.27–0.42) | 0.90 |
Mitral:tricuspid inflow ratio | 14 | 0.33 (0.26–0.41) | 0.82 (0.63–1.27) | 0.002 |
LVEDV:RVEDV ratio | 27 | 0.30 (0.25–0.40) | 0.57 (0.36–0.71) | <0.001 |
EDV: end-diastolic volume; EDP: end-diastolic pressure; EF: ejection fraction; EFE: endocardial fibroelastosis; i: indexed to body surface area; LV: left ventricle; LVEDV: left ventricular end-diastolic volume; MRI: magnetic resonance imaging; RV: right ventricle; RVEDV: right ventricular end-diastolic volume; SV: stroke volume.
P-value in bold indicates statistically significant.
Comparison of change in left and right heart structures before and after Super Glenn based on cardiac magnetic resonance imaging
MRI data . | ||||
---|---|---|---|---|
Variable . | N . | Pre-Super Glenn median (IQR) . | Post-Super Glenn median (IQR) . | P-value . |
i LV EDV (ml/m2) | 27 | 30.00 (23.88–36.53) | 51.96 (41.13–64.73) | <0.001 |
i LV ESV (ml/m2) | 27 | 11.94 (8.17–16.01) | 20.81 (15.29–28.22) | <0.001 |
i LV SV (ml/m2) | 27 | 16.91 (13.52–20.51) | 27.58 (24.66–37.19) | <0.001 |
LV EF (%) | 27 | 57.90 (54.20–64.00) | 60.90 (53.60–62.65) | 0.40 |
i LV mass (g/m2) | 25 | 24.38 (19.43–34.73) | 35.28 (27.97–42.46) | <0.001 |
LV mass/volume ratio | 24 | 0.85 (0.69–1.16) | 0.70 (0.58–0.76) | <0.001 |
i RV EDV (ml/m2) | 27 | 106.67 (82.70–119.83) | 86.96 (76.30–121.75) | 0.74 |
i RV ESV (ml/m2) | 27 | 43.75 (32.43–54.89) | 46.18 (39.08–68.14) | 0.12 |
i RV SV (ml/m2) | 27 | 55.00 (43.03–65.99) | 42.04 (37.60–51.99) | 0.068 |
RV EF (%) | 27 | 50.70 (48.95–58.95) | 48.90 (44.75–52.40) | <0.001 |
i RV mass (g/m2) | 25 | 38.80 (29.52–41.89) | 32.03 (26.61–45.76) | 0.41 |
RV mass/volume ratio | 25 | 0.36 (0.31–0.38) | 0.35 (0.27–0.42) | 0.90 |
Mitral:tricuspid inflow ratio | 14 | 0.33 (0.26–0.41) | 0.82 (0.63–1.27) | 0.002 |
LVEDV:RVEDV ratio | 27 | 0.30 (0.25–0.40) | 0.57 (0.36–0.71) | <0.001 |
MRI data . | ||||
---|---|---|---|---|
Variable . | N . | Pre-Super Glenn median (IQR) . | Post-Super Glenn median (IQR) . | P-value . |
i LV EDV (ml/m2) | 27 | 30.00 (23.88–36.53) | 51.96 (41.13–64.73) | <0.001 |
i LV ESV (ml/m2) | 27 | 11.94 (8.17–16.01) | 20.81 (15.29–28.22) | <0.001 |
i LV SV (ml/m2) | 27 | 16.91 (13.52–20.51) | 27.58 (24.66–37.19) | <0.001 |
LV EF (%) | 27 | 57.90 (54.20–64.00) | 60.90 (53.60–62.65) | 0.40 |
i LV mass (g/m2) | 25 | 24.38 (19.43–34.73) | 35.28 (27.97–42.46) | <0.001 |
LV mass/volume ratio | 24 | 0.85 (0.69–1.16) | 0.70 (0.58–0.76) | <0.001 |
i RV EDV (ml/m2) | 27 | 106.67 (82.70–119.83) | 86.96 (76.30–121.75) | 0.74 |
i RV ESV (ml/m2) | 27 | 43.75 (32.43–54.89) | 46.18 (39.08–68.14) | 0.12 |
i RV SV (ml/m2) | 27 | 55.00 (43.03–65.99) | 42.04 (37.60–51.99) | 0.068 |
RV EF (%) | 27 | 50.70 (48.95–58.95) | 48.90 (44.75–52.40) | <0.001 |
i RV mass (g/m2) | 25 | 38.80 (29.52–41.89) | 32.03 (26.61–45.76) | 0.41 |
RV mass/volume ratio | 25 | 0.36 (0.31–0.38) | 0.35 (0.27–0.42) | 0.90 |
Mitral:tricuspid inflow ratio | 14 | 0.33 (0.26–0.41) | 0.82 (0.63–1.27) | 0.002 |
LVEDV:RVEDV ratio | 27 | 0.30 (0.25–0.40) | 0.57 (0.36–0.71) | <0.001 |
EDV: end-diastolic volume; EDP: end-diastolic pressure; EF: ejection fraction; EFE: endocardial fibroelastosis; i: indexed to body surface area; LV: left ventricle; LVEDV: left ventricular end-diastolic volume; MRI: magnetic resonance imaging; RV: right ventricle; RVEDV: right ventricular end-diastolic volume; SV: stroke volume.
P-value in bold indicates statistically significant.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.